RWE and Patient-Centered Outcomes
Widespread availability of real-world data has enabled the generation of evidence and insights that benefit patients, providers, plans, and industry. When that evidence reflects patient outcomes, it provides an invaluable perspective on the consumer experience. Explore our real-world evidence (RWE) analyses and guidance to support your strategic decisions.
Webinar: Focus on Value: Understanding the Impact of Performance Contracting on Market Dynamics
Avalere hosts a series of webinars on “Navigating the New Dynamics of Outcomes Contracting and Risk Sharing Arrangements”. While traditional rebating and discounting terms have been a staple of industry contract negotiations, a new strategic focus is emerging on additional modes through which overall value can be measured for the wave of high-cost drugs now coming to shore.
Avalere Issues White Paper on the Management of High-Risk Medicare Populations in Partnership with The SCAN Foundation
New Avalere research for The SCAN Foundation demonstrates the ROI potential of well-targeted care coordination programs supported by robust data.
Avalere Heads to ISPOR with Panels and Presentations
Many of Avalere's experts are heading north to Canada for ISPOR's 19th Annual International Meeting, where we'll have several panel discussions and poster presentations.
Big Data Continues to Shape Healthcare in 2014
There is a rapid expansion of large and diverse data sets -- what is more commonly referred to as Big Data - as a result of the digitization of clinical and research data.
New Research: Real World Evidence
New Avalere research shows market demand for real world evidence (RWE), but a lack of stakeholder consensus on how to define it.